BioM2MetDisease: a manually curated database for associations between microRNAs, metabolites, small molecules and metabolic diseases

Abstract BioM2MetDisease is a manually curated database that aims to provide a comprehensive and experimentally supported resource of associations between metabolic diseases and various biomolecules. Recently, metabolic diseases such as diabetes have become one of the leading threats to people’s health. Metabolic disease associated with alterations of multiple types of biomolecules such as miRNAs and metabolites. An integrated and high-quality data source that collection of metabolic disease associated biomolecules is essential for exploring the underlying molecular mechanisms and discovering novel therapeutics. Here, we developed the BioM2MetDisease database, which currently documents 2681 entries of relationships between 1147 biomolecules (miRNAs, metabolites and small molecules/drugs) and 78 metabolic diseases across 14 species. Each entry includes biomolecule category, species, biomolecule name, disease name, dysregulation pattern, experimental technique, a brief description of metabolic disease-biomolecule relationships, the reference, additional annotation information etc. BioM2MetDisease provides a user-friendly interface to explore and retrieve all data conveniently. A submission page was also offered for researchers to submit new associations between biomolecules and metabolic diseases. BioM2MetDisease provides a comprehensive resource for studying biology molecules act in metabolic diseases, and it is helpful for understanding the molecular mechanisms and developing novel therapeutics for metabolic diseases. Database URL: http://www.bio-bigdata.com/BioM2MetDisease/

[1]  Chris Sander,et al.  An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma. , 2016, Cancer cell.

[2]  Eric J. Brunner,et al.  Metabolically healthy obesity and the risk of cardiovascular disease and type 2 diabetes: the Whitehall II cohort study , 2014, European heart journal.

[3]  Hyun-Young Park,et al.  Metabolic markers associated with insulin resistance predict type 2 diabetes in Koreans with normal blood pressure or prehypertension , 2016, Cardiovascular Diabetology.

[4]  Xia Li,et al.  Comprehensive analysis of the functional microRNA–mRNA regulatory network identifies miRNA signatures associated with glioma malignant progression , 2013, Nucleic acids research.

[5]  Johan Auwerx,et al.  Protein acetylation in metabolism — metabolites and cofactors , 2016, Nature Reviews Endocrinology.

[6]  D. Bartel MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.

[7]  D. Bartel,et al.  Predicting effective microRNA target sites in mammalian mRNAs , 2015, eLife.

[8]  Sarah Spiegel,et al.  Sphingosine-1-phosphate signaling and its role in disease. , 2012, Trends in cell biology.

[9]  Athanasios Fevgas,et al.  DIANA-miRGen v3.0: accurate characterization of microRNA promoters and their regulators , 2015, Nucleic Acids Res..

[10]  Inhye Park,et al.  Indoleamine 2,3-dioxygenase-1 is protective in atherosclerosis and its metabolites provide new opportunities for drug development , 2015, Proceedings of the National Academy of Sciences.

[11]  Dragan M. Svrakic,et al.  Depression in Type 2 Diabetes Mellitus: Prevalence, Impact, and Treatment , 2015, Drugs.

[12]  C. Harris,et al.  Biomarker development in the precision medicine era: lung cancer as a case study , 2016, Nature Reviews Cancer.

[13]  Peter Arner,et al.  MicroRNA regulatory networks in human adipose tissue and obesity , 2015, Nature Reviews Endocrinology.

[14]  Fabian J Theis,et al.  PhenomiR: a knowledgebase for microRNA expression in diseases and biological processes , 2010, Genome Biology.

[15]  Sung Hee Choi,et al.  Increasing Prevalence of Metabolic Syndrome in Korea , 2011, Diabetes Care.

[16]  JoAnn E. Manson,et al.  Genetic Predisposition to Central Obesity and Risk of Type 2 Diabetes: Two Independent Cohort Studies , 2015, Diabetes Care.

[17]  Hsien-Da Huang,et al.  miRTarBase 2016: updates to the experimentally validated miRNA-target interactions database , 2015, Nucleic Acids Res..

[18]  David S. Wishart,et al.  HMDB 3.0—The Human Metabolome Database in 2013 , 2012, Nucleic Acids Res..

[19]  Manuel Mayr,et al.  MicroRNAs in vascular and metabolic disease. , 2012, Circulation research.

[20]  A. Näär,et al.  MicroRNAs in metabolism and metabolic disorders , 2012, Nature Reviews Molecular Cell Biology.

[21]  Stefan Offermanns,et al.  Loss of FFA2 and FFA3 increases insulin secretion and improves glucose tolerance in type 2 diabetes , 2015, Nature Medicine.

[22]  Gang Fu,et al.  PubChem Substance and Compound databases , 2015, Nucleic Acids Res..

[23]  Ana Kozomara,et al.  miRBase: annotating high confidence microRNAs using deep sequencing data , 2013, Nucleic Acids Res..

[24]  Peng Wang,et al.  Lnc2Cancer: a manually curated database of experimentally supported lncRNAs associated with various human cancers , 2015, Nucleic Acids Res..

[25]  Andreas Kowarsch,et al.  PhenomiR: microRNAs in human diseases and biological processes. , 2012, Methods in molecular biology.

[26]  Marc Prentki,et al.  Insulin Resistance as a Physiological Defense Against Metabolic Stress: Implications for the Management of Subsets of Type 2 Diabetes , 2015, Diabetes.

[27]  Ning Liang,et al.  Loss of the co-repressor GPS2 sensitizes macrophage activation upon metabolic stress induced by obesity and type 2 diabetes , 2016, Nature Medicine.

[28]  Yadong Wang,et al.  miR2Disease: a manually curated database for microRNA deregulation in human disease , 2008, Nucleic Acids Res..

[29]  Wanchang Lin,et al.  Untargeted metabolic profiling identifies altered serum metabolites of type 2 diabetes mellitus in a prospective, nested case control study. , 2015, Clinical chemistry.

[30]  Nicolás Peláez,et al.  Biological robustness and the role of microRNAs: a network perspective. , 2012, Current topics in developmental biology.

[31]  Artemis G. Hatzigeorgiou,et al.  DIANA-miRPath v3.0: deciphering microRNA function with experimental support , 2015, Nucleic Acids Res..

[32]  Athanasios Fevgas,et al.  DIANA-TarBase v7.0: indexing more than half a million experimentally supported miRNA:mRNA interactions , 2014, Nucleic Acids Res..

[33]  Yang Li,et al.  HMDD v2.0: a database for experimentally supported human microRNA and disease associations , 2013, Nucleic Acids Res..

[34]  David S. Wishart,et al.  DrugBank 4.0: shedding new light on drug metabolism , 2013, Nucleic Acids Res..

[35]  Vladimir B. Bajic,et al.  FARNA: knowledgebase of inferred functions of non-coding RNA transcripts , 2016, Nucleic acids research.

[36]  Choon Nam Ong,et al.  Acetylcarnitine Is a Candidate Diagnostic and Prognostic Biomarker of Hepatocellular Carcinoma. , 2016, Cancer research.

[37]  Xing Chen,et al.  LncRNADisease: a database for long-non-coding RNA-associated diseases , 2012, Nucleic Acids Res..

[38]  A. Tahrani,et al.  Novel therapeutics for type 2 diabetes: insulin resistance , 2015, Diabetes, obesity & metabolism.